Replies to post #87881 on Amarantus Bioscience Holdings Inc (AMBS)

[zoomboom]

gonna go with 5

[Skeetz99]

I am going with #3 - Novartis....am speculating that a very significant cross licensing deal will occur by mid 2014 (right after we uplist to Nasdaq...this news will be the reality of what will reward our new institutional base and move the PPS much higher).

[Riskreturn168]

JPetrolnc: In your list of PD Phase 2 drug candidates, I notice you have left off Medgenesis' GDNF. Is that not also a Phase 2 PD drug? The whole point of someone having us license us their Phase 2 PD would be to use in a cocktail form with MANF. A MJFF official talked earlier this year, as was posted today, about the probability of forming cocktails to sure PD. Why not GDNF and MANF, for PD or for LID?

[MUKA1]

Fun to look back on this stream of "dot connecting" from several months ago when good dd speculated of the recent news..